The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|2|111-124

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.2, 2004-03, pp. : 111-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Application of Emerging Technologies in Genomics and Proteomics to Drug Development

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 1, 2003-03 ,pp. : 7-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Genomics in Antibacterial Target Discovery

By  

Current Medicinal Chemistry, Vol. 8, Iss. 14, 2001-12 ,pp. : 1713-1726

Bentham Science Publishers

Access to resources Recommend Favorite

Chemical genomics as an emerging paradigm for postgenomic drug discovery

By Salemme F Raymond  

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 257-267

Future Medicine

Access to resources Recommend Favorite

The role of murine models of prostate cancer in drug target discovery and validation

By Ahmad Imran   Sansom Owen J   Leung Hing Y  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 879-888

Informa Healthcare

Access to resources Recommend Favorite

Genomics and proteomics tools for compound mode-of-action studies in drug discovery

By Kley Nikolai   Ivanov Igor   Meier-Ewert Sebastian  

Pharmacogenomics, Vol. 5, Iss. 4, 2004-06 ,pp. : 395-404

Future Medicine

Access to resources Recommend Favorite